| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | rRNA binding | 7.53e-05 | 79 | 21 | 3 | GO:0019843 | |
| GeneOntologyMolecularFunction | chromatin binding | 8.50e-04 | 739 | 21 | 5 | GO:0003682 | |
| GeneOntologyMolecularFunction | core promoter sequence-specific DNA binding | 1.51e-03 | 55 | 21 | 2 | GO:0001046 | |
| GeneOntologyMolecularFunction | general transcription initiation factor activity | 2.30e-03 | 68 | 21 | 2 | GO:0140223 | |
| GeneOntologyMolecularFunction | histone binding | 2.58e-03 | 265 | 21 | 3 | GO:0042393 | |
| GeneOntologyMolecularFunction | p53 binding | 2.94e-03 | 77 | 21 | 2 | GO:0002039 | |
| GeneOntologyBiologicalProcess | rRNA transcription | 1.15e-05 | 46 | 20 | 3 | GO:0009303 | |
| GeneOntologyBiologicalProcess | protein-DNA complex assembly | 8.63e-05 | 249 | 20 | 4 | GO:0065004 | |
| GeneOntologyBiologicalProcess | rRNA metabolic process | 1.27e-04 | 275 | 20 | 4 | GO:0016072 | |
| GeneOntologyBiologicalProcess | protein-DNA complex organization | 2.74e-04 | 999 | 20 | 6 | GO:0071824 | |
| GeneOntologyBiologicalProcess | nucleolar large rRNA transcription by RNA polymerase I | 2.86e-04 | 26 | 20 | 2 | GO:0042790 | |
| MousePheno | delayed parturition | 1.23e-05 | 5 | 16 | 2 | MP:0012008 | |
| Domain | ARM-like | 1.02e-05 | 270 | 21 | 5 | IPR011989 | |
| Domain | LisH | 4.47e-04 | 28 | 21 | 2 | IPR006594 | |
| Domain | LISH | 4.47e-04 | 28 | 21 | 2 | PS50896 | |
| Domain | LisH | 4.47e-04 | 28 | 21 | 2 | SM00667 | |
| Domain | BROMODOMAIN_1 | 7.83e-04 | 37 | 21 | 2 | PS00633 | |
| Domain | Bromodomain | 8.26e-04 | 38 | 21 | 2 | PF00439 | |
| Domain | BROMODOMAIN_2 | 9.62e-04 | 41 | 21 | 2 | PS50014 | |
| Domain | BROMO | 1.01e-03 | 42 | 21 | 2 | SM00297 | |
| Domain | Bromodomain | 1.01e-03 | 42 | 21 | 2 | IPR001487 | |
| Domain | - | 1.01e-03 | 42 | 21 | 2 | 1.20.920.10 | |
| Domain | - | 1.88e-03 | 222 | 21 | 3 | 1.25.10.10 | |
| Domain | Homeodomain-like | 5.84e-03 | 332 | 21 | 3 | IPR009057 | |
| Domain | ARM-type_fold | 6.19e-03 | 339 | 21 | 3 | IPR016024 | |
| Domain | Znf_FYVE_PHD | 1.17e-02 | 147 | 21 | 2 | IPR011011 | |
| Domain | RRM_1 | 2.26e-02 | 208 | 21 | 2 | PF00076 | |
| Domain | RRM | 2.44e-02 | 217 | 21 | 2 | SM00360 | |
| Domain | RRM_dom | 2.65e-02 | 227 | 21 | 2 | IPR000504 | |
| Domain | RRM | 2.72e-02 | 230 | 21 | 2 | PS50102 | |
| Pathway | PID_MYC_ACTIV_PATHWAY | 9.00e-05 | 79 | 16 | 3 | M66 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_THE_AP_2_TFAP2_FAMILY_OF_TRANSCRIPTION_FACTORS | 3.86e-04 | 26 | 16 | 2 | MM15502 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_THE_AP_2_TFAP2_FAMILY_OF_TRANSCRIPTION_FACTORS | 8.29e-04 | 38 | 16 | 2 | M27757 | |
| Pathway | PID_AURORA_B_PATHWAY | 8.73e-04 | 39 | 16 | 2 | M14 | |
| Pathway | WP_MRNA_PROCESSING | 1.39e-03 | 451 | 16 | 4 | MM15946 | |
| Pathway | REACTOME_RRNA_PROCESSING | 1.48e-03 | 205 | 16 | 3 | M27685 | |
| Pathway | WP_PATHOGENIC_ESCHERICHIA_COLI_INFECTION | 1.73e-03 | 55 | 16 | 2 | M39613 | |
| Pathway | KEGG_PATHOGENIC_ESCHERICHIA_COLI_INFECTION | 1.79e-03 | 56 | 16 | 2 | M2333 | |
| Pubmed | 1.76e-09 | 191 | 22 | 6 | 20195357 | ||
| Pubmed | ABH2 couples regulation of ribosomal DNA transcription with DNA alkylation repair. | 2.19e-09 | 5 | 22 | 3 | 23972994 | |
| Pubmed | A Chemical Proteomics Approach to Reveal Direct Protein-Protein Interactions in Living Cells. | 6.20e-09 | 35 | 22 | 4 | 29104064 | |
| Pubmed | 3.82e-07 | 2 | 22 | 2 | 2100262 | ||
| Pubmed | 3.82e-07 | 2 | 22 | 2 | 21310483 | ||
| Pubmed | C23 interacts with B23, a putative nucleolar-localization-signal-binding protein. | 3.82e-07 | 2 | 22 | 2 | 8620867 | |
| Pubmed | [Features of the Structure and Expression of NPM and NCL Genes in Cutaneous Melanoma]. | 3.82e-07 | 2 | 22 | 2 | 31397440 | |
| Pubmed | 3.82e-07 | 2 | 22 | 2 | 20713446 | ||
| Pubmed | AML-associated mutation of nucleophosmin compromises its interaction with nucleolin. | 3.82e-07 | 2 | 22 | 2 | 30130654 | |
| Pubmed | 3.82e-07 | 2 | 22 | 2 | 1903428 | ||
| Pubmed | 3.82e-07 | 2 | 22 | 2 | 32234886 | ||
| Pubmed | 3.82e-07 | 2 | 22 | 2 | 10503877 | ||
| Pubmed | FGF13A interacts with NPM1 and UBF and inhibits the invasion of bladder cancer cells. | 1.15e-06 | 3 | 22 | 2 | 37603967 | |
| Pubmed | 1.15e-06 | 3 | 22 | 2 | 24991885 | ||
| Pubmed | Nucleolar localization of the ErbB3 receptor as a new target in glioblastoma. | 1.15e-06 | 3 | 22 | 2 | 35255831 | |
| Pubmed | 1.15e-06 | 3 | 22 | 2 | 16777843 | ||
| Pubmed | Identification of Microprotein-Protein Interactions via APEX Tagging. | 1.15e-06 | 3 | 22 | 2 | 28589727 | |
| Pubmed | 2.29e-06 | 4 | 22 | 2 | 22362753 | ||
| Pubmed | 2.29e-06 | 4 | 22 | 2 | 18173745 | ||
| Pubmed | 2.29e-06 | 4 | 22 | 2 | 14636574 | ||
| Pubmed | 2.29e-06 | 4 | 22 | 2 | 14729462 | ||
| Pubmed | 2.29e-06 | 4 | 22 | 2 | 12878164 | ||
| Pubmed | 2.29e-06 | 4 | 22 | 2 | 17215513 | ||
| Pubmed | 2.29e-06 | 4 | 22 | 2 | 26231209 | ||
| Pubmed | 2.29e-06 | 4 | 22 | 2 | 20075868 | ||
| Pubmed | 2.29e-06 | 4 | 22 | 2 | 9642267 | ||
| Pubmed | Nucleophosmin is essential for ribosomal protein L5 nuclear export. | 3.82e-06 | 5 | 22 | 2 | 16648475 | |
| Pubmed | 3.82e-06 | 5 | 22 | 2 | 17674968 | ||
| Pubmed | 5.72e-06 | 6 | 22 | 2 | 11812799 | ||
| Pubmed | 5.72e-06 | 6 | 22 | 2 | 19450526 | ||
| Pubmed | Myc promotes polyploidy in murine trophoblast cells and suppresses senescence. | 8.01e-06 | 7 | 22 | 2 | 37278344 | |
| Pubmed | Dido3-dependent SFPQ recruitment maintains efficiency in mammalian alternative splicing. | 8.01e-06 | 7 | 22 | 2 | 30931476 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | 1.01e-05 | 1294 | 22 | 7 | 30804502 | |
| Pubmed | The RNA-binding protein HuR is a novel target of Pirh2 E3 ubiquitin ligase. | 1.04e-05 | 220 | 22 | 4 | 34091597 | |
| Pubmed | 1.07e-05 | 8 | 22 | 2 | 16129783 | ||
| Pubmed | 1.27e-05 | 72 | 22 | 3 | 12777385 | ||
| Pubmed | 1.44e-05 | 75 | 22 | 3 | 25593309 | ||
| Pubmed | 1.59e-05 | 245 | 22 | 4 | 21182205 | ||
| Pubmed | Maternal DCAF13 Regulates Chromatin Tightness to Contribute to Embryonic Development. | 2.09e-05 | 11 | 22 | 2 | 31000741 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | 2.15e-05 | 954 | 22 | 6 | 36373674 | |
| Pubmed | Nucleophosmin deposition during mRNA 3' end processing influences poly(A) tail length. | 2.51e-05 | 12 | 22 | 2 | 21822216 | |
| Pubmed | 2.51e-05 | 12 | 22 | 2 | 15989966 | ||
| Pubmed | Ebp1 sumoylation, regulated by TLS/FUS E3 ligase, is required for its anti-proliferative activity. | 2.51e-05 | 12 | 22 | 2 | 19946338 | |
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | 2.63e-05 | 989 | 22 | 6 | 36424410 | |
| Pubmed | A feedforward circuit shaped by ECT2 and USP7 contributes to breast carcinogenesis. | 2.97e-05 | 13 | 22 | 2 | 32929379 | |
| Pubmed | Disruption of the lamin A and matrin-3 interaction by myopathic LMNA mutations. | 3.02e-05 | 96 | 22 | 3 | 25948554 | |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | 3.31e-05 | 608 | 22 | 5 | 36089195 | |
| Pubmed | Human BRE1 is an E3 ubiquitin ligase for Ebp1 tumor suppressor. | 3.46e-05 | 14 | 22 | 2 | 19037095 | |
| Pubmed | 3.49e-05 | 615 | 22 | 5 | 31048545 | ||
| Pubmed | 4.06e-05 | 106 | 22 | 3 | 12429849 | ||
| Pubmed | Tandem immunoprecipitation approach to identify HIV-1 Gag associated host factors. | 4.56e-05 | 16 | 22 | 2 | 24690621 | |
| Pubmed | 4.64e-05 | 653 | 22 | 5 | 22586326 | ||
| Pubmed | 4.79e-05 | 112 | 22 | 3 | 28416769 | ||
| Pubmed | ZBTB2 protein is a new partner of the Nucleosome Remodeling and Deacetylase (NuRD) complex. | 5.09e-05 | 330 | 22 | 4 | 33301849 | |
| Pubmed | A genome-wide RNAi screen identifies multiple synthetic lethal interactions with the Ras oncogene. | 5.15e-05 | 331 | 22 | 4 | 19490893 | |
| Pubmed | 5.21e-05 | 332 | 22 | 4 | 25693804 | ||
| Pubmed | Widespread Expansion of Protein Interaction Capabilities by Alternative Splicing. | 8.50e-05 | 742 | 22 | 5 | 26871637 | |
| Pubmed | Importance of EGFR/ERCC1 interaction following radiation-induced DNA damage. | 8.76e-05 | 22 | 22 | 2 | 24780295 | |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | 9.45e-05 | 759 | 22 | 5 | 35915203 | |
| Pubmed | 9.69e-05 | 142 | 22 | 3 | 30809309 | ||
| Pubmed | 1.28e-04 | 419 | 22 | 4 | 15635413 | ||
| Pubmed | 1.33e-04 | 27 | 22 | 2 | 19602484 | ||
| Pubmed | TRIM28-mediated nucleocapsid protein SUMOylation enhances SARS-CoV-2 virulence. | 1.41e-04 | 430 | 22 | 4 | 38172120 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | 1.50e-04 | 1353 | 22 | 6 | 29467282 | |
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | 1.54e-04 | 440 | 22 | 4 | 34244565 | |
| Pubmed | 1.58e-04 | 847 | 22 | 5 | 35850772 | ||
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | 1.58e-04 | 847 | 22 | 5 | 35235311 | |
| Pubmed | Proteomic analysis of complexes formed by human topoisomerase I. | 1.87e-04 | 32 | 22 | 2 | 15848144 | |
| Pubmed | Nucleophosmin serves as a rate-limiting nuclear export chaperone for the Mammalian ribosome. | 1.87e-04 | 32 | 22 | 2 | 18809582 | |
| Pubmed | Interaction proteomics of the HMGA chromatin architectural factors. | 1.87e-04 | 32 | 22 | 2 | 18850631 | |
| Pubmed | 1.87e-04 | 32 | 22 | 2 | 21951318 | ||
| Pubmed | Protein kinase DYRK2 is a scaffold that facilitates assembly of an E3 ligase. | 2.24e-04 | 35 | 22 | 2 | 19287380 | |
| Pubmed | 2.38e-04 | 36 | 22 | 2 | 16622419 | ||
| Pubmed | 2.47e-04 | 195 | 22 | 3 | 19454010 | ||
| Pubmed | PML interacts with Myc, and Myc target gene expression is altered in PML-null fibroblasts. | 2.51e-04 | 37 | 22 | 2 | 15735755 | |
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | 2.74e-04 | 202 | 22 | 3 | 33005030 | |
| Pubmed | 2.99e-04 | 208 | 22 | 3 | 11790298 | ||
| Pubmed | Characterization of the DOT1L network: implications of diverse roles for DOT1L. | 3.09e-04 | 41 | 22 | 2 | 20431927 | |
| Pubmed | 3.24e-04 | 42 | 22 | 2 | 24997765 | ||
| Pubmed | 3.61e-04 | 222 | 22 | 3 | 37071664 | ||
| Pubmed | 3.72e-04 | 45 | 22 | 2 | 33596420 | ||
| Pubmed | 3.91e-04 | 228 | 22 | 3 | 30471916 | ||
| Pubmed | SIRT7-dependent deacetylation of the U3-55k protein controls pre-rRNA processing. | 4.41e-04 | 49 | 22 | 2 | 26867678 | |
| Pubmed | 4.59e-04 | 50 | 22 | 2 | 32068487 | ||
| Pubmed | MDM2 mediates nonproteolytic polyubiquitylation of the DEAD-Box RNA helicase DDX24. | 4.59e-04 | 50 | 22 | 2 | 24980433 | |
| Pubmed | Ablation of the oncogenic transcription factor ERG by deubiquitinase inhibition in prostate cancer. | 4.97e-04 | 52 | 22 | 2 | 24591637 | |
| Pubmed | HDAC6 activity is not required for basal autophagic flux in metastatic prostate cancer cells. | 4.97e-04 | 52 | 22 | 2 | 26643866 | |
| Pubmed | 5.04e-04 | 601 | 22 | 4 | 33658012 | ||
| Pubmed | 5.16e-04 | 53 | 22 | 2 | 15047060 | ||
| Pubmed | 5.17e-04 | 251 | 22 | 3 | 28077445 | ||
| Pubmed | CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality. | 5.17e-04 | 605 | 22 | 4 | 28977666 | |
| Pubmed | CIN85 interacting proteins in B cells-specific role for SHIP-1. | 5.36e-04 | 54 | 22 | 2 | 21725061 | |
| Pubmed | 5.66e-04 | 259 | 22 | 3 | 9811942 | ||
| Pubmed | SNIP1 Recruits TET2 to Regulate c-MYC Target Genes and Cellular DNA Damage Response. | 5.66e-04 | 259 | 22 | 3 | 30404004 | |
| Pubmed | 5.66e-04 | 259 | 22 | 3 | 31162944 | ||
| Pubmed | 5.73e-04 | 260 | 22 | 3 | 36199071 | ||
| Pubmed | Molecular Characterization of the Oncogene BTF3 and Its Targets in Colorectal Cancer. | 5.88e-04 | 626 | 22 | 4 | 33644029 | |
| Pubmed | Regulation of alternative splicing by SRrp86 and its interacting proteins. | 5.97e-04 | 57 | 22 | 2 | 14559993 | |
| Interaction | POLR1E interactions | 1.55e-06 | 350 | 22 | 6 | int:POLR1E | |
| Interaction | PES1 interactions | 7.29e-06 | 258 | 22 | 5 | int:PES1 | |
| Interaction | PNMA8A interactions | 8.59e-06 | 122 | 22 | 4 | int:PNMA8A | |
| Interaction | POLR1G interactions | 1.06e-05 | 489 | 22 | 6 | int:POLR1G | |
| Interaction | RPP25 interactions | 3.90e-05 | 61 | 22 | 3 | int:RPP25 | |
| Interaction | NUP43 interactions | 4.24e-05 | 625 | 22 | 6 | int:NUP43 | |
| Interaction | CENPA interactions | 4.52e-05 | 377 | 22 | 5 | int:CENPA | |
| Interaction | RNF8 interactions | 7.63e-05 | 421 | 22 | 5 | int:RNF8 | |
| Interaction | RPL22 interactions | 9.39e-05 | 440 | 22 | 5 | int:RPL22 | |
| Interaction | IRF1 interactions | 9.80e-05 | 83 | 22 | 3 | int:IRF1 | |
| Interaction | BIVM interactions | 1.03e-04 | 14 | 22 | 2 | int:BIVM | |
| Interaction | SIRT7 interactions | 1.11e-04 | 744 | 22 | 6 | int:SIRT7 | |
| Interaction | RPL23AP32 interactions | 1.13e-04 | 87 | 22 | 3 | int:RPL23AP32 | |
| Interaction | H3-3A interactions | 1.16e-04 | 749 | 22 | 6 | int:H3-3A | |
| Interaction | CTCF interactions | 1.17e-04 | 461 | 22 | 5 | int:CTCF | |
| Interaction | C3orf49 interactions | 1.18e-04 | 15 | 22 | 2 | int:C3orf49 | |
| Interaction | MDK interactions | 1.29e-04 | 91 | 22 | 3 | int:MDK | |
| Interaction | ZNF816 interactions | 1.35e-04 | 16 | 22 | 2 | int:ZNF816 | |
| Interaction | CBX8 interactions | 1.40e-04 | 249 | 22 | 4 | int:CBX8 | |
| Interaction | TAF1D interactions | 1.42e-04 | 94 | 22 | 3 | int:TAF1D | |
| Interaction | WWP1 interactions | 1.65e-04 | 260 | 22 | 4 | int:WWP1 | |
| Interaction | KNOP1 interactions | 1.96e-04 | 272 | 22 | 4 | int:KNOP1 | |
| Interaction | RPS24 interactions | 2.22e-04 | 529 | 22 | 5 | int:RPS24 | |
| Interaction | ZNF543 interactions | 2.36e-04 | 21 | 22 | 2 | int:ZNF543 | |
| Interaction | NOP53 interactions | 2.44e-04 | 288 | 22 | 4 | int:NOP53 | |
| Interaction | WDR87 interactions | 2.59e-04 | 22 | 22 | 2 | int:WDR87 | |
| Interaction | CCDC140 interactions | 2.71e-04 | 117 | 22 | 3 | int:CCDC140 | |
| Interaction | TEX15 interactions | 2.84e-04 | 23 | 22 | 2 | int:TEX15 | |
| Interaction | SULF2 interactions | 2.85e-04 | 119 | 22 | 3 | int:SULF2 | |
| Interaction | SP110 interactions | 3.06e-04 | 122 | 22 | 3 | int:SP110 | |
| Interaction | MTF1 interactions | 3.14e-04 | 123 | 22 | 3 | int:MTF1 | |
| Interaction | SLX4 interactions | 3.19e-04 | 572 | 22 | 5 | int:SLX4 | |
| Interaction | HPSE2 interactions | 3.36e-04 | 25 | 22 | 2 | int:HPSE2 | |
| Interaction | PARP1 interactions | 3.56e-04 | 1316 | 22 | 7 | int:PARP1 | |
| Interaction | RCHY1 interactions | 3.86e-04 | 325 | 22 | 4 | int:RCHY1 | |
| Interaction | CENPW interactions | 3.93e-04 | 27 | 22 | 2 | int:CENPW | |
| Interaction | MAP10 interactions | 4.54e-04 | 29 | 22 | 2 | int:MAP10 | |
| Interaction | LINC01554 interactions | 4.78e-04 | 142 | 22 | 3 | int:LINC01554 | |
| Interaction | HIVEP2 interactions | 4.86e-04 | 30 | 22 | 2 | int:HIVEP2 | |
| Interaction | ZNF223 interactions | 4.86e-04 | 30 | 22 | 2 | int:ZNF223 | |
| Interaction | BYSL interactions | 4.89e-04 | 346 | 22 | 4 | int:BYSL | |
| Interaction | MAGEB2 interactions | 5.05e-04 | 349 | 22 | 4 | int:MAGEB2 | |
| Interaction | SNRNP40 interactions | 5.23e-04 | 637 | 22 | 5 | int:SNRNP40 | |
| Interaction | DAXX interactions | 5.27e-04 | 353 | 22 | 4 | int:DAXX | |
| Interaction | SMC5 interactions | 5.53e-04 | 1000 | 22 | 6 | int:SMC5 | |
| Interaction | SOX2 interactions | 5.70e-04 | 1422 | 22 | 7 | int:SOX2 | |
| Interaction | EIF6 interactions | 5.98e-04 | 365 | 22 | 4 | int:EIF6 | |
| Interaction | ZBTB7B interactions | 6.04e-04 | 366 | 22 | 4 | int:ZBTB7B | |
| Interaction | HAND2 interactions | 6.25e-04 | 34 | 22 | 2 | int:HAND2 | |
| Interaction | EED interactions | 6.28e-04 | 1445 | 22 | 7 | int:EED | |
| Interaction | LYAR interactions | 6.49e-04 | 373 | 22 | 4 | int:LYAR | |
| Interaction | ZBTB48 interactions | 6.53e-04 | 158 | 22 | 3 | int:ZBTB48 | |
| Interaction | WDR43 interactions | 6.65e-04 | 159 | 22 | 3 | int:WDR43 | |
| Interaction | AATF interactions | 6.68e-04 | 376 | 22 | 4 | int:AATF | |
| Interaction | RPL7A interactions | 6.99e-04 | 679 | 22 | 5 | int:RPL7A | |
| Interaction | POLR1B interactions | 7.02e-04 | 162 | 22 | 3 | int:POLR1B | |
| Interaction | RPL37A interactions | 7.74e-04 | 391 | 22 | 4 | int:RPL37A | |
| Interaction | UTP4 interactions | 8.07e-04 | 170 | 22 | 3 | int:UTP4 | |
| Interaction | RPL10 interactions | 8.13e-04 | 702 | 22 | 5 | int:RPL10 | |
| Interaction | WDR46 interactions | 8.49e-04 | 173 | 22 | 3 | int:WDR46 | |
| Interaction | IFI16 interactions | 8.77e-04 | 714 | 22 | 5 | int:IFI16 | |
| Interaction | SRPK2 interactions | 8.94e-04 | 717 | 22 | 5 | int:SRPK2 | |
| Interaction | ZNF692 interactions | 9.54e-04 | 42 | 22 | 2 | int:ZNF692 | |
| Interaction | ABT1 interactions | 1.04e-03 | 423 | 22 | 4 | int:ABT1 | |
| Interaction | NOG interactions | 1.09e-03 | 45 | 22 | 2 | int:NOG | |
| Interaction | NIFK interactions | 1.11e-03 | 431 | 22 | 4 | int:NIFK | |
| Interaction | UTP23 interactions | 1.13e-03 | 191 | 22 | 3 | int:UTP23 | |
| Interaction | RPL4 interactions | 1.19e-03 | 764 | 22 | 5 | int:RPL4 | |
| Interaction | FBXO25 interactions | 1.25e-03 | 198 | 22 | 3 | int:FBXO25 | |
| Interaction | PWP1 interactions | 1.25e-03 | 198 | 22 | 3 | int:PWP1 | |
| Interaction | ZNF330 interactions | 1.26e-03 | 446 | 22 | 4 | int:ZNF330 | |
| Interaction | RPL18A interactions | 1.27e-03 | 447 | 22 | 4 | int:RPL18A | |
| Interaction | H3-4 interactions | 1.28e-03 | 448 | 22 | 4 | int:H3-4 | |
| Interaction | ZBTB2 interactions | 1.30e-03 | 450 | 22 | 4 | int:ZBTB2 | |
| Interaction | LRRC31 interactions | 1.38e-03 | 205 | 22 | 3 | int:LRRC31 | |
| Interaction | MACROH2A1 interactions | 1.39e-03 | 458 | 22 | 4 | int:MACROH2A1 | |
| Interaction | BRWD1 interactions | 1.40e-03 | 51 | 22 | 2 | int:BRWD1 | |
| Interaction | H3C15 interactions | 1.42e-03 | 207 | 22 | 3 | int:H3C15 | |
| Interaction | MYBBP1A interactions | 1.45e-03 | 463 | 22 | 4 | int:MYBBP1A | |
| Interaction | FAM90A1 interactions | 1.48e-03 | 210 | 22 | 3 | int:FAM90A1 | |
| Interaction | GRB2 interactions | 1.51e-03 | 806 | 22 | 5 | int:GRB2 | |
| Interaction | OSGIN1 interactions | 1.52e-03 | 53 | 22 | 2 | int:OSGIN1 | |
| Interaction | DOT1L interactions | 1.52e-03 | 807 | 22 | 5 | int:DOT1L | |
| Interaction | TLE1 interactions | 1.55e-03 | 213 | 22 | 3 | int:TLE1 | |
| Interaction | C7orf50 interactions | 1.65e-03 | 218 | 22 | 3 | int:C7orf50 | |
| Interaction | DDX23 interactions | 1.65e-03 | 480 | 22 | 4 | int:DDX23 | |
| Interaction | POLR1A interactions | 1.70e-03 | 220 | 22 | 3 | int:POLR1A | |
| Interaction | RPGR interactions | 1.75e-03 | 57 | 22 | 2 | int:RPGR | |
| Interaction | WWP2 interactions | 1.81e-03 | 840 | 22 | 5 | int:WWP2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2q37 | 1.69e-04 | 226 | 22 | 3 | chr2q37 | |
| Cytoband | 2q37.1 | 4.76e-04 | 67 | 22 | 2 | 2q37.1 | |
| GeneFamily | RNA binding motif containing | 1.31e-02 | 213 | 15 | 2 | 725 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | 1.99e-02 | 718 | 15 | 3 | 28 | |
| Coexpression | GSE3203_HEALTHY_VS_INFLUENZA_INFECTED_LN_BCELL_UP | 2.16e-05 | 200 | 22 | 4 | M6785 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_B_emap-30374_k-means-cluster#2_top-relative-expression-ranked_1000 | 3.62e-05 | 379 | 22 | 5 | gudmap_developingLowerUrinaryTract_P1_bladder_B_1000_k2 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_testes_emap-11164_top-relative-expression-ranked_1000 | 1.37e-04 | 814 | 22 | 6 | gudmap_developingGonad_e18.5_testes_1000 | |
| CoexpressionAtlas | DevelopingGonad_P2_testes_emap-30171_top-relative-expression-ranked_1000 | 1.42e-04 | 819 | 22 | 6 | gudmap_developingGonad_P2_testes_1000 | |
| ToppCell | facs-Large_Intestine-Distal-18m-Epithelial-epithelial_cell_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.20e-06 | 173 | 21 | 4 | a5172dee859bf6c2eed46c48bd64dfef0ff9f28f | |
| ToppCell | facs-Large_Intestine-Distal-18m-Epithelial-Lgr5-_amplifying_undifferentiated_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.20e-06 | 173 | 21 | 4 | 639b5b0b33ce5aa0bc26363c059717012ddc14c0 | |
| ToppCell | Cerebellum-Endothelial-MURAL-M1(Rgs5Acta2)-M1_3-MURAL_Mural.Acta2Rgs5.Rgs5_(Mural.Acta2Rgs5.Rgs5)|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 3.30e-05 | 134 | 21 | 3 | 1fa13185a4dfb4563473184c0c4f449011d88631 | |
| ToppCell | Cerebellum-Endothelial-MURAL-M1(Rgs5Acta2)-M1_3-MURAL_Mural.Acta2Rgs5.Rgs5_(Mural.Acta2Rgs5.Rgs5)-|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 3.30e-05 | 134 | 21 | 3 | 1ab99a22d0d7657f62f8ea7d96bb24e88de54fd4 | |
| ToppCell | Cerebellum-Endothelial-MURAL-M1(Rgs5Acta2)-M1_3|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 3.30e-05 | 134 | 21 | 3 | 8a3acf32cabc37b49d6488d43cdaae7cec79d119 | |
| ToppCell | (04)_Pre-ciliated-(2)_48hpi|(04)_Pre-ciliated / shred by cell type and Timepoint | 5.50e-05 | 159 | 21 | 3 | e1f36b237e314ef6a18224eb8f3b97a612c39506 | |
| ToppCell | 10x5'v1-week_12-13-Hematopoietic-HSC/MPP_and_pro-MEP|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 6.03e-05 | 164 | 21 | 3 | 47355439e578d1b1a387fb4ee761162028abea4a | |
| ToppCell | LPS-antiTNF-Endothelial-Mes-Like-Alv_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.25e-05 | 166 | 21 | 3 | 94a00edf66d54bc5f7343daea700ca26cf38fd90 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Lymphoid-CD4/CD8-Reg_T-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.47e-05 | 168 | 21 | 3 | 187b98664843a304406f086ea696adbf32283d07 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-proliferative_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.59e-05 | 169 | 21 | 3 | a84490724a206c9bbb145f7ce08613f91d100ac4 | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Rectal_Adenocarcinoma-7|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 7.68e-05 | 178 | 21 | 3 | edc76b8f15056ec1c9a1c61a048b6331a92592d6 | |
| ToppCell | Cerebellum-Endothelial-MURAL-M1(Rgs5Acta2)|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 8.21e-05 | 182 | 21 | 3 | da61e7cb2537c567968d8bd8baf537ecdff0ab18 | |
| ToppCell | Cerebellum-Endothelial-MURAL|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 8.21e-05 | 182 | 21 | 3 | b2f03f61aebb5920595fed8b9d6799a09353419b | |
| ToppCell | E12.5-Mesenchymal-developing_mesenchymal_cell-mesenchymal_myogenic_precursor_(Axin2+)|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 8.34e-05 | 183 | 21 | 3 | 523896bd1a93bdda81a009768baa3a1bdbd108b8 | |
| ToppCell | PND10-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B-B-B_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.34e-05 | 183 | 21 | 3 | 956ff95aef9c5521b6a3ba7ac6df0aad242c1c35 | |
| ToppCell | COVID-19_Mild-Neu_4|COVID-19_Mild / 5 Neutrophil clusters in COVID-19 patients | 8.89e-05 | 187 | 21 | 3 | 714851e757c71c559ee6413a3f61d6c117c79ad2 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.18e-05 | 189 | 21 | 3 | 975e7aa3b862a8b07c2ab8426a14f5cc54998aca | |
| ToppCell | Myeloid-Myeloid-B_(Activated_Macrophage)|Myeloid / shred on cell class and cell subclass (v4) | 9.47e-05 | 191 | 21 | 3 | 7bf125249af1e8bb138ed4d999fdd74b03ab2447 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.47e-05 | 191 | 21 | 3 | 08042952431ca1a6fd7dfc13f36eb28643979598 | |
| ToppCell | COVID-19_Severe-Lymphoid_T/NK-CD4+_T_activated|COVID-19_Severe / Disease group, lineage and cell class | 9.76e-05 | 193 | 21 | 3 | beb862d38b88572836b0a797c8efef7a2492e0b9 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.76e-05 | 193 | 21 | 3 | f4310faa13fc8ce99a217e2d1c9cc733683797a1 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 9.76e-05 | 193 | 21 | 3 | f8af695457d2a0a911a5ac491742465864ebda37 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.76e-05 | 193 | 21 | 3 | 2901d7a9672a8cf70c9f1c752685b45e4d79ac70 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 9.76e-05 | 193 | 21 | 3 | 089aece40130034a89a5213be778f10b0787eeba | |
| ToppCell | systemic_lupus_erythematosus-flare|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.05e-04 | 198 | 21 | 3 | 4c93ee921d56132d80832d8e94563f32ccf13bbc | |
| ToppCell | Tracheal-10x3prime_v2-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.07e-04 | 199 | 21 | 3 | 056a28c36cd58dc695a5ae6f29b62135d6aad819 | |
| ToppCell | Tracheal-10x3prime_v2-Stromal-Myofibroblastic|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.07e-04 | 199 | 21 | 3 | 534dcfe8b65ad92bb8d749d1c7036ad4807e09cd | |
| ToppCell | 3'-Child04-06-SmallIntestine-Hematopoietic-B_cells-Cycling_B_cell|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.07e-04 | 199 | 21 | 3 | 8b7f84a1e385c6a9bd45a5d41f75e30819dbe32d | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Mesenchymal-immature_mesenchymal_cell-Mesoderm_2_(ZEB2+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.07e-04 | 199 | 21 | 3 | 1f5ad0f1971156b28a8d46a380bda906b5fdbedc | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW23|organoid_Tanaka_cellReport / Sample Type, Dataset, Time_group, and Cell type. | 1.08e-04 | 200 | 21 | 3 | e16bde12326f0cfc4d03f9307cba0e21ea2389cb | |
| ToppCell | COVID-19-COVID-19_Severe-Lymphocyte-T/NK-CD4+_T_activated|COVID-19_Severe / Disease, condition lineage and cell class | 1.08e-04 | 200 | 21 | 3 | deeed668b129e66156b5f6abe1a07a9bf842a14d | |
| ToppCell | Hippocampus-Neuronal-Inhibitory-iN2(Gad1Gad2)-Htr1b-Inhibitory_Gad1Gad2_Htr3a.Htr1b_(Interneuron,__(candidate_CGE-derived_11))|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 4.24e-04 | 65 | 21 | 2 | 2cf855eed46ba9e1354ac3b5c18d4adcc3e0e7a5 | |
| ToppCell | Hippocampus-Neuronal-Inhibitory-iN2(Gad1Gad2)-Htr1b-Inhibitory_Gad1Gad2_Htr3a.Htr1b_(Interneuron,__(candidate_CGE-derived_11))-|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 4.24e-04 | 65 | 21 | 2 | f44998b87dc7015b79ca8f8d60f9d7845755b8bb | |
| ToppCell | Hippocampus-Neuronal-Inhibitory-iN2(Gad1Gad2)-Htr1b|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 4.24e-04 | 65 | 21 | 2 | 9a4c853e2723a23b537d2966c6583909d0d0aeb2 | |
| ToppCell | Thalamus-Endothelial-MURAL-M1(Rgs5Acta2)-M1_3-MURAL_Mural.Rgs5Acta2.Car4_(Mural.Rgs5Acta2.Car4)|Thalamus / BrainAtlas - Mouse McCarroll V32 | 6.90e-04 | 83 | 21 | 2 | 59fce941d45f9763a8584f3fd5b7c0738de9f592 | |
| ToppCell | Thalamus-Endothelial-MURAL-M1(Rgs5Acta2)-M1_3-MURAL_Mural.Rgs5Acta2.Car4_(Mural.Rgs5Acta2.Car4)-|Thalamus / BrainAtlas - Mouse McCarroll V32 | 6.90e-04 | 83 | 21 | 2 | ebabce70dc01fdeda7fccebc2c4a0b686cda580f | |
| ToppCell | Thalamus-Endothelial-MURAL-M1(Rgs5Acta2)-M1_3|Thalamus / BrainAtlas - Mouse McCarroll V32 | 6.90e-04 | 83 | 21 | 2 | 4017af9a4804a06d0f2cd0f285ebf1b582b751de | |
| ToppCell | Hippocampus-Endothelial-MURAL-M1(Rgs5Acta2)-M1_3-MURAL_Mural.Rgs5Acta2.Ccnd1_(Mural.Rgs5Acta2.Ccnd1)-|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 7.75e-04 | 88 | 21 | 2 | 5fdfc72988dcbb7d2025866b2b00eab8f11f332f | |
| ToppCell | Hippocampus-Endothelial-MURAL-M1(Rgs5Acta2)-M1_3-MURAL_Mural.Rgs5Acta2.Ccnd1_(Mural.Rgs5Acta2.Ccnd1)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 7.75e-04 | 88 | 21 | 2 | b9874366925fa1c08a74b14c3c6e127b9dffa23e | |
| ToppCell | Thalamus-Endothelial-MURAL-M1(Rgs5Acta2)-M1_1-MURAL_Mural.Rgs5Acta2.Cnn1_(Mural.Rgs5Acta2.Cnn1)|Thalamus / BrainAtlas - Mouse McCarroll V32 | 7.93e-04 | 89 | 21 | 2 | 2c19e2dc979d0f86539a044ae49f126caff50fbb | |
| ToppCell | Thalamus-Endothelial-MURAL-M1(Rgs5Acta2)-M1_1-MURAL_Mural.Rgs5Acta2.Cnn1_(Mural.Rgs5Acta2.Cnn1)-|Thalamus / BrainAtlas - Mouse McCarroll V32 | 7.93e-04 | 89 | 21 | 2 | 442931182f7eb87f16c19774607eb14b44cd7ec7 | |
| ToppCell | Thalamus-Endothelial-MURAL-M1(Rgs5Acta2)-M1_1|Thalamus / BrainAtlas - Mouse McCarroll V32 | 7.93e-04 | 89 | 21 | 2 | 05ba2c31bb4bd8c7ad4bcbbefe818c08136101b2 | |
| ToppCell | Frontal_cortex-Endothelial-MURAL-M1(Rgs5Acta2)-M1_3|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 9.79e-04 | 99 | 21 | 2 | 8aab2a6989d342af387bd0823f79e7b326a12430 | |
| ToppCell | Frontal_cortex-Endothelial-MURAL-M1(Rgs5Acta2)-M1_2-MURAL_Mural.Rgs5Acta2.Abcc9_(Mural.Rgs5Acta2.Abcc9)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 1.04e-03 | 102 | 21 | 2 | 72ce247dad7404e6b9c971b5c29d3c6846da5efc | |
| ToppCell | Frontal_cortex-Endothelial-MURAL-M1(Rgs5Acta2)-M1_2-MURAL_Mural.Rgs5Acta2.Abcc9_(Mural.Rgs5Acta2.Abcc9)-|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 1.04e-03 | 102 | 21 | 2 | 8c4d9483ff983538593f4e17f4a74a93cdda59c4 | |
| ToppCell | Frontal_cortex-Endothelial-MURAL-M1(Rgs5Acta2)-M1_2|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 1.04e-03 | 102 | 21 | 2 | 5feedce6d26a578c4aaba4e4824b3d0c3f3806bc | |
| ToppCell | Entopeduncular-Endothelial-MURAL-M1(Rgs5Acta2)-M1_3|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 1.30e-03 | 114 | 21 | 2 | 108cc5b04cc7c59310eb55dc2c44ae2b8e0b05e4 | |
| ToppCell | Endothelial-Endothelial-A|Endothelial / shred on cell class and cell subclass (v4) | 1.48e-03 | 122 | 21 | 2 | 65849d1296934d5765afd006cbb6739383b9f49f | |
| ToppCell | Hippocampus-Endothelial-MURAL-M1(Rgs5Acta2)-M1_3|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.58e-03 | 126 | 21 | 2 | b0bc61be1d4ce8114077c524fedfdf89128bcf12 | |
| ToppCell | Thalamus-Endothelial-MURAL-M1(Rgs5Acta2)|Thalamus / BrainAtlas - Mouse McCarroll V32 | 1.58e-03 | 126 | 21 | 2 | 333f83f9ba64d46f22fee328d0a691fd5818bdac | |
| ToppCell | Thalamus-Endothelial-MURAL|Thalamus / BrainAtlas - Mouse McCarroll V32 | 1.58e-03 | 126 | 21 | 2 | cf571f36761da3540fb445de89d555cbce8a47ab | |
| ToppCell | Substantia_nigra-Endothelial-MURAL-M1(Rgs5Acta2)-M1_1|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.60e-03 | 127 | 21 | 2 | 8c972ea21797ee46d6c67e91cfd2e2e2ce016248 | |
| ToppCell | E18.5-samps-Mesenchymal-Myofibroblast-myofibroblast_-_immature|E18.5-samps / Age Group, Lineage, Cell class and subclass | 1.78e-03 | 134 | 21 | 2 | a4b9163af68e92d047b0005fd2f98aa63846b65b | |
| ToppCell | Posterior_cortex-Endothelial-MURAL-M1(Rgs5Acta2)-M1_2|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.81e-03 | 135 | 21 | 2 | e908aacb72a8c340f06cf5b4a6b70c2faac4d027 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell_cycling-Cycling_Connecting_Tubule_Cell_S-high|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.91e-03 | 139 | 21 | 2 | c9bf98bed77415a1438f3f9e441a1346e75c26b0 | |
| ToppCell | Globus_pallidus-Endothelial-MURAL-M1(Rgs5Acta2)-M1_3-MURAL_Mural.Rgs5Acta2.Pappa2_(Mural.Rgs5Acta2.Pappa2)|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.97e-03 | 141 | 21 | 2 | a32947b13e888850c979a54c137512e4b96d2f36 | |
| ToppCell | Globus_pallidus-Endothelial-MURAL-M1(Rgs5Acta2)-M1_3-MURAL_Mural.Rgs5Acta2.Pappa2_(Mural.Rgs5Acta2.Pappa2)-|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.97e-03 | 141 | 21 | 2 | 2cb651d63466fdcce011d1dd8de409ef439d03e7 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c05-FOS|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.00e-03 | 142 | 21 | 2 | ae495c8dd733f0fde66bddc281606543f21c0d4b | |
| ToppCell | Globus_pallidus-Endothelial-MURAL-M1(Rgs5Acta2)-M1_3|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 2.02e-03 | 143 | 21 | 2 | 9bfb3674c8f011b9cf928b522777b8d54478db8d | |
| ToppCell | Entopeduncular-Endothelial-MURAL-M1(Rgs5Acta2)-M1_1|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 2.14e-03 | 147 | 21 | 2 | 27e97a7b1dc296f52990b5810a52ab0a7ef2b9e6 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell_cycling|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.17e-03 | 148 | 21 | 2 | 18cfecd6ae20edb74f5d44ba759909df356acf3a | |
| ToppCell | PND03-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B-B-B_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.22e-03 | 150 | 21 | 2 | d6b977dd47aa017f6ba762f0c505cd896caa523f | |
| ToppCell | Pericytes-IPF_04|World / lung cells shred on cell class, cell subclass, sample id | 2.22e-03 | 150 | 21 | 2 | dbc202bd6db4fb5c8b2abd1200e074a2a9e63a59 | |
| ToppCell | Frontal_cortex-Endothelial-MURAL|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 2.25e-03 | 151 | 21 | 2 | 7570372a315bc312ff57bb5f483375c401ae8787 | |
| ToppCell | Frontal_cortex-Endothelial-MURAL-M1(Rgs5Acta2)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 2.25e-03 | 151 | 21 | 2 | 527059e47e381b2f6d63c1abb39bc0795ee3829d | |
| ToppCell | 10x5'v1-week_12-13-Hematopoietic-HSC/MPP_and_pro-myeloid_DC_progenitor|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.28e-03 | 152 | 21 | 2 | bffbbdf1047c59e5241c99dc10b36cfe2071aa48 | |
| ToppCell | E18.5-samps-Endothelial-Mature_fetal_endothelial-capillary_endothelial_Hpgd-CA4_high|E18.5-samps / Age Group, Lineage, Cell class and subclass | 2.34e-03 | 154 | 21 | 2 | 212c340a096a3a9669d1aebd61c045cf1402a868 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.37e-03 | 155 | 21 | 2 | e7f49e2fdaf184fa6b4e685518004e7deff1316d | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.37e-03 | 155 | 21 | 2 | 5a872ca70ae8c30b57f45a6772d7bf565e0c2663 | |
| ToppCell | PND14-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B-B-B_prolif|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.40e-03 | 156 | 21 | 2 | 6f8622716bad4e505f241a2a4ef953bf3fc6dbfa | |
| ToppCell | 368C-Myeloid-Monocyte-CD16+_Monocyte|368C / Donor, Lineage, Cell class and subclass (all cells) | 2.40e-03 | 156 | 21 | 2 | 25b0936960be4955b6a6d6b8a867fdd4be548f05 | |
| ToppCell | Hippocampus-Endothelial-MURAL|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 2.46e-03 | 158 | 21 | 2 | 2d73b5e59c650c603fec6223b1c51f0962f7bc81 | |
| ToppCell | E18.5-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_prolif|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.46e-03 | 158 | 21 | 2 | f61ebe3a316e4259387cd9da83707f15e6473cae | |
| ToppCell | 10x5'v1-week_14-16-Myeloid_DC-DC-DC_precursor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.46e-03 | 158 | 21 | 2 | 5d8a345df1d3001f34740b9f2f5f92f5428bbee6 | |
| ToppCell | Hippocampus-Endothelial-MURAL-M1(Rgs5Acta2)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 2.46e-03 | 158 | 21 | 2 | 7f4a644534b78f7e7539cae1fd895dad6f96862b | |
| ToppCell | facs-Heart-RV-24m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.46e-03 | 158 | 21 | 2 | 2ef43d14ee65d004dc62c12ff209bbe12e4db681 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Pvalb-Pvalb_Gpr149_Islr|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.49e-03 | 159 | 21 | 2 | c64fff8d89f84d1f5a0cc432e31f56f741162505 | |
| ToppCell | Bac-SEP-Lymphocyte-T_NK-dnT|Bac-SEP / Disease, Lineage and Cell Type | 2.52e-03 | 160 | 21 | 2 | f5ca49801c981b903a85a64b21ece6b59fe91cbc | |
| ToppCell | TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma-Stomach_Adenocarcinoma_-_Diffuse-6|TCGA-Stomach / Sample_Type by Project: Shred V9 | 2.62e-03 | 163 | 21 | 2 | c1a98d6776b685f20dde049715233e5c73ce3244 | |
| ToppCell | 356C-Myeloid-Macrophage-SPP1+_Macrophage|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 2.65e-03 | 164 | 21 | 2 | d6806deabf5f5c355934387be2baae125ac33fb8 | |
| ToppCell | wk_15-18-Epithelial-Airway_epithelial_progenitor-epi-stalk_intermediate|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.68e-03 | 165 | 21 | 2 | 4297588f809e8a8275ab1a6ed99daac7ad93bd61 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_3-Exc_L3_RORB_CARTPT|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.68e-03 | 165 | 21 | 2 | 00c1d9fce3a017d05ec02133e56be371ab2148f1 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_T/NK-CD8-positive,_alpha-beta_T_cell-CD8_T_cells-CD8_T_cells_L.1.1.0.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.71e-03 | 166 | 21 | 2 | 26f3d5e5e30b63b09b89cda23c423d12d887631f | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-Chondrocyte-Chondrocyte_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.71e-03 | 166 | 21 | 2 | 37794a84601a2a949d579663d4a4bb8bc8fb5923 | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Colon_Adenocarcinoma-4|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 2.71e-03 | 166 | 21 | 2 | 52293b8a74d46e6161fb6a2e7e86e51fd9e89a5b | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-Chondrocyte|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.71e-03 | 166 | 21 | 2 | 81c546c6d847e49e662b81e71992ca0f7a99e890 | |
| ToppCell | facs-Tongue-nan-24m-Epithelial|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.75e-03 | 167 | 21 | 2 | 73fdf4b81a45ec686d2929eaf641b434f70b7898 | |
| ToppCell | facs-Tongue-nan-24m|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.75e-03 | 167 | 21 | 2 | c4157fb31b44fe7c44be4215dda8ae2d37cf49a8 | |
| ToppCell | Control-Myeloid-MoAM1,_IL1R2|Myeloid / Condition, Lineage and Cell class | 2.75e-03 | 167 | 21 | 2 | 6e5140527437193f441ca96893b9a00d346614f3 | |
| ToppCell | droplet-Liver-LIVER_HEPATOCYTES-30m-Lymphocytic|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.75e-03 | 167 | 21 | 2 | e1b1a952fce27ab9cf16919b290625ff4a75261e | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_prolif|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.75e-03 | 167 | 21 | 2 | b0eb7a40491dd2432f5282f578ce569df86d21a7 | |
| ToppCell | 10x3'2.3-week_17-19-Hematopoietic-HSC/MPP_and_pro-myeloid_DC_progenitor|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.78e-03 | 168 | 21 | 2 | 2c42588ca9775270591485f9bf805fe8ab9c0671 | |
| ToppCell | Substantia_nigra-Endothelial-MURAL|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 2.78e-03 | 168 | 21 | 2 | 271a81c59a9a75bac6107c68fead03e7f35bc192 | |
| ToppCell | Substantia_nigra-Endothelial-MURAL-M1(Rgs5Acta2)|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 2.78e-03 | 168 | 21 | 2 | b220e732eb7b204fc263a9f2e8ddae6bf9fa98f4 | |
| ToppCell | facs-Tongue-nan-24m-Epithelial-nan|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.81e-03 | 169 | 21 | 2 | 0054f9bfd4d377c7fd94873c1308622051c59a8e | |
| ToppCell | Posterior_cortex-Endothelial-MURAL|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 2.81e-03 | 169 | 21 | 2 | 0ae65daf092396b71f790b65c7a2feed90397417 | |
| ToppCell | facs-Heart-LV-18m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.81e-03 | 169 | 21 | 2 | 849a8f8509c58d65462a09c84d58b6ecdc8934f5 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell_cycling-Cycling_Distal_Convoluted_Tubule_Cell_S-high|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.81e-03 | 169 | 21 | 2 | e7514956b2e4298222ec443f98b2f5289451786e | |
| ToppCell | Posterior_cortex-Endothelial-MURAL-M1(Rgs5Acta2)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 2.81e-03 | 169 | 21 | 2 | 8cd70ce27b1cecb83f8a376230e7ef41b079b124 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.81e-03 | 169 | 21 | 2 | 335619507857383c3b0b507cdf05d786ed59e585 | |
| Computational | Genes in the cancer module 457. | 3.49e-05 | 10 | 10 | 2 | MODULE_457 | |
| Computational | rRNA processing and DNA repair. | 1.18e-04 | 18 | 10 | 2 | MODULE_392 | |
| Computational | Neighborhood of PPP1CC | 1.17e-03 | 56 | 10 | 2 | GCM_PPP1CC | |
| Computational | Genes in the cancer module 418. | 1.34e-03 | 60 | 10 | 2 | MODULE_418 | |
| Computational | Neighborhood of TPT1 | 1.82e-03 | 70 | 10 | 2 | GCM_TPT1 | |
| Computational | Neighborhood of NPM1 | 1.92e-03 | 72 | 10 | 2 | GNF2_NPM1 | |
| Computational | Neighborhood of PSME1 | 2.67e-03 | 85 | 10 | 2 | GCM_PSME1 | |
| Drug | 4-nitrobiphenyl | 2.53e-06 | 28 | 22 | 3 | CID000007114 | |
| Drug | hedamycin | 3.81e-06 | 32 | 22 | 3 | CID000098033 | |
| Drug | reverse T | 2.33e-05 | 58 | 22 | 3 | CID000064973 | |
| Drug | MS-3 | 2.49e-05 | 8 | 22 | 2 | CID000100450 | |
| Drug | Thiostrepton [1393-48-2]; Down 200; 2.4uM; PC3; HT_HG-U133A | 3.12e-05 | 191 | 22 | 4 | 4563_DN | |
| Drug | 17-AAG; Down 200; 1uM; HL60; HT_HG-U133A | 3.31e-05 | 194 | 22 | 4 | 1166_DN | |
| Drug | AC1MM84E | 3.44e-05 | 66 | 22 | 3 | CID003256856 | |
| Drug | aspartylaspartic acid | 8.05e-05 | 14 | 22 | 2 | CID000332965 | |
| Drug | toyocamycin | 8.05e-05 | 14 | 22 | 2 | CID000011824 | |
| Drug | uranium | 9.16e-05 | 252 | 22 | 4 | CID000023989 | |
| Disease | ferritin measurement | 2.92e-03 | 119 | 20 | 2 | EFO_0004459 | |
| Disease | Intellectual Disability | 3.25e-03 | 447 | 20 | 3 | C3714756 | |
| Disease | Vertigo | 3.96e-03 | 139 | 20 | 2 | HP_0002321 | |
| Disease | hemoglobin A1 measurement | 4.96e-03 | 520 | 20 | 3 | EFO_0007629 | |
| Disease | electrocardiography | 5.23e-03 | 530 | 20 | 3 | EFO_0004327 | |
| Disease | Myocardial Ischemia | 6.26e-03 | 176 | 20 | 2 | C0151744 | |
| Disease | X-12063 measurement | 6.97e-03 | 186 | 20 | 2 | EFO_0021283 | |
| Disease | Adenocarcinoma of lung (disorder) | 8.48e-03 | 206 | 20 | 2 | C0152013 | |
| Disease | monocyte count | 1.09e-02 | 1320 | 20 | 4 | EFO_0005091 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| EEEAEDDEDEDDDED | 1686 | Q86V15 | |
| DDEDEDDDEDDDDED | 1691 | Q86V15 | |
| DDDEDDDDEDDDEDD | 1696 | Q86V15 | |
| DDDEDDDEDDDDEDL | 1701 | Q86V15 | |
| EEEDEEDDEDDESDD | 616 | Q9UIF8 | |
| DGEDEDDEDDDDDDD | 256 | Q6PL18 | |
| DDEDDDDDDDDDDDD | 261 | Q6PL18 | |
| DDDDDDDDDDDDEDD | 266 | Q6PL18 | |
| DDDDDDDEDDEDEED | 271 | Q6PL18 | |
| DTDDDDDDDDDDDDD | 36 | Q9BXN1 | |
| DDDDDDDDDDDEDNS | 41 | Q9BXN1 | |
| DEDDDDDDEEDDDED | 161 | P06748 | |
| DDDEEDDDEDDDDDD | 166 | P06748 | |
| DDDEDDDDDDFDDEE | 171 | P06748 | |
| EENDDDDDDDDEEDG | 231 | Q9NW13 | |
| EEDDDEDDDDTDDLD | 1411 | Q9Y4B6 | |
| WDDDEDDDDEEEEDD | 131 | O95751 | |
| ESDDDEDEDDEEDHD | 581 | Q7Z3E5 | |
| DEEEDDDSEEDEEDD | 146 | P19338 | |
| DDSEEDEEDDEDEDE | 151 | P19338 | |
| DEDDEDDEDDEDDDD | 186 | P19338 | |
| DDEDDEDDDDDEEDD | 191 | P19338 | |
| EDEEEDDEDEDDDDD | 236 | P19338 | |
| DDEDEDDDDDEDDED | 241 | P19338 | |
| DDDDDEDDEDDDDED | 246 | P19338 | |
| EDDEDDDDEDDEEEE | 251 | P19338 | |
| EEDDEEEDDEDEDDD | 516 | P07199 | |
| EEDDEDEDDDDDEED | 521 | P07199 | |
| EEEEEEEDDDDDDDD | 531 | Q8IX15 | |
| NNDDDEDEDDEDEDE | 331 | Q5H9L4 | |
| EDEDDEDEDEDEDED | 336 | Q5H9L4 | |
| DDDDDDDDDDDNIDD | 301 | O94763 | |
| EDEDDDDEEDNDEDD | 341 | Q7Z6M4 | |
| DDEEDNDEDDNDEDD | 346 | Q7Z6M4 | |
| NDEDDNDEDDDDEDD | 351 | Q7Z6M4 | |
| NDEDDDDEDDDEAED | 356 | Q7Z6M4 | |
| DDEDDDEAEDNDEDE | 361 | Q7Z6M4 | |
| DEEEEDEEDEEDDDD | 196 | B2RPK0 | |
| DDDDDDDDDDDDDDD | 246 | P23327 | |
| TEDDDDDDDEDDDDE | 221 | Q969K3 | |
| DDDDEDDDDEEENAE | 226 | Q969K3 | |
| EDDKEDDDDDEDDDD | 136 | A1YPR0 | |
| DDDDDEDDDDEEDEE | 141 | A1YPR0 | |
| DEDEDEDDEEDFEDD | 486 | O00401 | |
| EDDEDEDDDEDDDED | 726 | P17480 | |
| EDDDEDDDEDEDNES | 731 | P17480 | |
| EDGDDNDDDDEDEDD | 1906 | P31629 |